QUANTIFY
Status timeline
- 4 Apr 2024Application received from the International Bureau (Madrid)Sn Assigned For Sect 66a Appl From Ib
- 18 Jul 2024Assigned to an examining attorneyAssigned To Examiner
- 26 Jul 2024Office action issuedNon-Final Action Written
- 30 Jan 2025Response to office action filedTeas Response To Office Action Received
- 25 Feb 2025Approved for publicationApproved For Pub - Principal Register
- 18 Mar 2025Published for oppositionPublished For Opposition
- 6 May 2025Registered on the Principal RegisterRegistered-Principal Register
All 25 USPTO events
| 2025-12-18 | Final Decision Transaction Processed By Ib |
| 2025-12-02 | Final Disposition Notice Sent To Ib |
| 2025-12-01 | Final Disposition Processed |
| 2025-09-19 | Notification Of Possible Opposition - Processed By Ib |
| 2025-09-03 | Notification Of Possible Opposition Created, To Be Sent To Ib |
| 2025-09-03 | Notification Of Possible Opposition Sent To Ib |
| 2025-08-06 | Final Disposition Notice Created, To Be Sent To Ib |
| 2025-05-06 | Registered-Principal Register |
| 2025-05-06 | Notice Of Registration Confirmation Emailed |
| 2025-03-18 | Published For Opposition |
| 2025-03-18 | Official Gazette Publication Confirmation E-Mailed |
| 2025-03-12 | Notification Of Notice Of Publication E-Mailed |
| 2025-02-25 | Approved For Pub - Principal Register |
| 2025-01-30 | Teas Response To Office Action Received |
| 2025-01-30 | Correspondence Received In Law Office |
| 2025-01-30 | Teas/Email Correspondence Entered |
| 2024-09-01 | Refusal Processed By Ib |
| 2024-08-09 | Refusal Processed By Mpu |
| 2024-08-09 | Non-Final Action Mailed - Refusal Sent To Ib |
| 2024-07-27 | Non-Final Action (Ib Refusal) Prepared For Review |
| 2024-07-26 | Non-Final Action Written |
| 2024-07-18 | Assigned To Examiner |
| 2024-04-09 | Application Filing Receipt Mailed |
| 2024-04-05 | New Application Office Supplied Data Entered |
| 2024-04-04 | Sn Assigned For Sect 66a Appl From Ib |
Goods & services
Class 42 Technology & SaaS
Medical research; medical and pharmacological medical research services; scientific research for medical purposes; scientific research; consultancy in the field of scientific research, namely, scientific research consulting in the field of Real World Evidence (RWE) and Health Economics and Outcome Research (HEOR) for the pharmaceutical, biotechnology and healthcare industries; scientific research; scientific research and analysis in the nature of Real World Evidence (RWE)-based data analysis and Health Economics and Outcome Research (HEOR)-focused data analysis for scientific research purposes
Source & freshness
Source: USPTO Trademark Applications bulk data. This record was last updated by the USPTO file dated 3 Apr 2026; the index was built on 20 Nov 2026 and covers USPTO data through 31 Aug 2026. Open the official USPTO record (TSDR) → If the two differ, the USPTO record is correct.